Square Pharmaceuticals Limited announced earnings results for the second quarter ended December 31, 2019. For the second quarter, the company announced total revenue was BDT 11,129.202 million compared to BDT 10,776.321 million a year ago. Operating income was BDT 3,728.484 million compared to BDT 3,412.447 million a year ago. Net income was BDT 3,531.973 million compared to BDT 3,126.368 million a year ago. Basic earnings per share was BDT 4.18 compared to BDT 3.7 a year ago. For the half year, total revenue was BDT 22,422.785 million compared to BDT 21,318.399 million a year ago. Operating income was BDT 7,419.564 million compared to BDT 7,055.373 million a year ago. Net income was BDT 6,885.810 million compared to BDT 6,295.232 million a year ago. Basic earnings per share was BDT 8.16 compared to BDT 7.46 a year ago.